We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Have you been eager to see how HCA Healthcare, Inc. (HCA - Free Report) performed in Q3 in comparison with the market expectations?
Let’s quickly scan through the key facts from this leading hospital company’s earnings release this morning.
Earnings Meet Estimates
HCA Healthcare came out with adjusted earnings per share of $1.21, in line with the Zacks Consensus Estimate. Earnings declined nearly 25% year over year.
You should note that the earnings estimate for HCA Healthcare depicted neutral stance prior to the earnings release. The Zacks Consensus Estimate remained unchanged at $1.21 per share over the last 7 days.
HCA Healthcare has a decent earnings surprise history.
Overall, the company surpassed the Zacks Consensus Estimate by an average of nearly 3.58% in the trailing four quarters.
Revenue In Line
HCA Healthcare posted revenues of $10.67 billion, almost inline with Zacks Consensus Estimate. The reported figure was up from 4.2% from the year-ago quarter.
Key Stats to Note
Adjusted EBITDA totaled $1.8 billion up 9.2% year over year.
Same facility equivalent admissions increased 0.3% year over year, while same facility admissions increased 0.6%. Same facility revenue per equivalent admission increased 2%.
Expenses increased 6.5% year over year to $9.9 billion.
As of Sep 30, 2017, HCA Healthcare operated 177 hospitals and 119 freestanding surgery centers.
The board of directors has approved an additional share repurchase program for up to $2 billion.
Guidance
The expects 2017 revenues in the range of $43 billion -$44 billion, adjusted EBIDTA of $ 8–$8.2 billion, EPS of $6.45–$6.70 and capital expenditures of about $3 billion.
What Zacks Rank Says
HCA Healthcare carries a Zacks Rank #5 (Strong Sell). However, since the latest earnings performance is yet to be reflected in the estimate revisions, the rank is subject to change.
Check back later for our full write up on this HCA Healthcare earnings report!
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Image: Bigstock
HCA Healthcare (HCA) Q3 Earnings, Revenues Meet Estimates
Have you been eager to see how HCA Healthcare, Inc. (HCA - Free Report) performed in Q3 in comparison with the market expectations?
Let’s quickly scan through the key facts from this leading hospital company’s earnings release this morning.
Earnings Meet Estimates
HCA Healthcare came out with adjusted earnings per share of $1.21, in line with the Zacks Consensus Estimate. Earnings declined nearly 25% year over year.
HCA Holdings, Inc. Price and EPS Surprise
HCA Holdings, Inc. Price and EPS Surprise | HCA Holdings, Inc. Quote
How Was the Estimate Revision Trend?
You should note that the earnings estimate for HCA Healthcare depicted neutral stance prior to the earnings release. The Zacks Consensus Estimate remained unchanged at $1.21 per share over the last 7 days.
HCA Healthcare has a decent earnings surprise history.
Overall, the company surpassed the Zacks Consensus Estimate by an average of nearly 3.58% in the trailing four quarters.
Revenue In Line
HCA Healthcare posted revenues of $10.67 billion, almost inline with Zacks Consensus Estimate. The reported figure was up from 4.2% from the year-ago quarter.
Key Stats to Note
Adjusted EBITDA totaled $1.8 billion up 9.2% year over year.
Same facility equivalent admissions increased 0.3% year over year, while same facility admissions increased 0.6%. Same facility revenue per equivalent admission increased 2%.
Expenses increased 6.5% year over year to $9.9 billion.
As of Sep 30, 2017, HCA Healthcare operated 177 hospitals and 119 freestanding surgery centers.
The board of directors has approved an additional share repurchase program for up to $2 billion.
Guidance
The expects 2017 revenues in the range of $43 billion -$44 billion, adjusted EBIDTA of $ 8–$8.2 billion, EPS of $6.45–$6.70 and capital expenditures of about $3 billion.
What Zacks Rank Says
HCA Healthcare carries a Zacks Rank #5 (Strong Sell). However, since the latest earnings performance is yet to be reflected in the estimate revisions, the rank is subject to change.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Check back later for our full write up on this HCA Healthcare earnings report!
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Click for details >>